Parmantier & Cie. sets Evonik price target at EUR 20.50, rates stock Hold
Bitget2026/10/06 14:31Parmantier & Cie. set a Halten rating on Evonik, dated Oct. 6, 2026. Price target set at EUR 20.50 with a 6-month horizon. Call published in the firm’s sector report “European Chemicals: The 2027 Cycle,” framing 2027 as a restructuring-driven upcycle. Report flagged BASF-Evonik contact talks as a potential catalyst, with no agreed transaction and key terms still uncertain. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evonik Industries AG published the original content used to generate this news brief via EQS News (Ref. ID: rc_27020) on October 06, 2026, and is solely responsible for the information contained therein.
- Parmantier & Cie. set a Halten rating on Evonik, dated Oct. 6, 2026.
- Price target set at EUR 20.50 with a 6-month horizon.
- Call published in the firm’s sector report “European Chemicals: The 2027 Cycle,” framing 2027 as a restructuring-driven upcycle.
- Report flagged BASF-Evonik contact talks as a potential catalyst, with no agreed transaction and key terms still uncertain.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Needham raises CrowdStrike target price to $310
Morgan Stanley raises CME Group price target to $337
Chip design software leader Synopsys seeks collaboration with Chinese large model laboratories
